A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus, as reported this week in the online edition of the journal Molecular Pharmaceutics.
The University of Texas at Austin President Bill Powers sent this statement to the campus community today.
AUSTIN, Texas — As Ebola continues to spread in West Africa, it may be silently immunizing large numbers of people who never fall ill or infect others, yet become protected from future infection. If such immunity is confirmed, it would have significant ramifications on projections of how widespread the disease will be and could help determine… » Continue Reading
University of Texas at Austin Pharmacy Researcher Receives $2.6 Million to Develop Vaccine Against Ebola Virus
Dr. Maria Croyle, associate professor of pharmaceutics at The University of Texas at Austin College of Pharmacy, has received $2.6 million to develop a vaccine against Ebola virus infection.